UR9A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clinuvel Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 4.88 EUR -0.81% Market Closed

Market Cap: €244.6m

	Clinuvel Pharmaceuticals Ltd F:UR9A	AU
	01 Communique Laboratory Inc XTSX:ONE	CA
R	Readcrest Capital AG F:EXJ	DE
P	Pacific Biosciences of California Inc F:P09	US
	Impinj Inc NASDAQ:PI	US
O	OHTL PCL SET:OHTL	TH
R	Rupert Resources Ltd TSX:RUP	CA
	Vanadi Coffee SA MAD:VANA	ES
D	DigitalOcean Holdings Inc XBER:0SU	US
R	Riverview Rubber Estates Bhd KLSE:RVIEW	MY
P	Prestige Biologics Co Ltd KOSDAQ:334970	KR

Profitability Summary

Clinuvel Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

98%

Gross Margin is Increasing

94% > 95%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

52%

Declining Operating Margin

56% > 45%

Exceptional Net Margin

34%

Strong 3Y Average Net Margin

38%

Declining Net Margin

39% > 34%

Exceptional Free Cash Flow Margin

42%

Strong 3Y Average Free Cash Flow Margin

38%

Declining Free Cash Flow Margin

46% > 42%

Positive ROE

14%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

108%

Declining ROIC

122% > 108%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.